LONDON: In a news release, Schroders Capital Global Innovation Trust plc (INOV) has announced its final results for the fiscal year ending December 31, 2023. The company, under the leadership of Chair Tim Edwards, has reported a notable increase in net asset value (NAV) during the last quarter, signaling a positive shift towards growth in…
All posts tagged Schroders Capital Global Innovation Trust
Schroders Capital Global Innovation Trust invests in Neurona Therapeutics
LONDON, UK: Schroders Capital Global Innovation Trust has made an investment of $1.6 million (£1.3 million) in Neurona Therapeutics, a US-based clinical-stage cell therapy company. The Company participated in Neurona’s Series E financing round, which raised $120 million and was co-led by Viking Global Investors and Cormorant Asset Management with participation from new and existing…
Schroders Capital Global Innovation Trust makes investment in Memo Therapeutics
LONDON: Schroders Capital Global Innovation Trust has made a commitment of CHF 0.9 million (£0.8 million) to Memo Therapeutics AG, a Switzerland-based clinical-stage biopharmaceutical company. The Company participated in Memo’s Series C financing round, which raised CHF 25 million and was led by Pureos Bioventures. Existing investors Swisscanto, Vesalius Biocapital, Adjuvant Capital, Verve Ventures, GF…